SCHEMBL29465008

SCHEMBL29465008

O=C(O)[C@@H](O)c1ccccc1Cl

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 2/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ FABP4 P15090 1/20 0.51
▸ FABP5 Q01469 1/20 0.51
▸ CASP1 P29466 1/20 0.50
▸ ACP3 P15309 1/20 0.47
▸ ALDH1A1 P00352 1/20 0.45
▸ IGFBP3 P17936 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ CXCL8 P10145 1/20 0.44
▸ CYP2D6 P10635 1/20 0.43
▸ GLS O94925 1/20 0.42
▸ AOC3 Q16853 1/20 0.42
▸ ADRB2 P07550 1/20 0.42
▸ ADRB1 P08588 1/20 0.42
▸ CES2 O00748 1/20 0.41
▸ CES1 P23141 1/20 0.41
▸ KDM4C Q9H3R0 1/20 0.41
▸ IDO1 P14902 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28162814 1.00 LMNA (0.52) LMNAMAPK1FABP4FABP5CASP1
SCHEMBL197618 1.00 LMNA (0.52) LMNAMAPK1FABP4FABP5CASP1
SCHEMBL29398319 1.00 LMNA (0.52) LMNAMAPK1FABP4FABP5CASP1
SCHEMBL28162815 1.00 LMNA (0.52) LMNAMAPK1FABP4FABP5CASP1
SCHEMBL24733 1.00 LMNA (0.52) LMNAMAPK1FABP4FABP5CASP1
SCHEMBL24732 1.00 LMNA (0.52) LMNAMAPK1FABP4FABP5CASP1
SCHEMBL29501895 1.00 LMNA (0.52) LMNAMAPK1FABP4FABP5CASP1
SCHEMBL28848826 0.98 LMNA (0.50) LMNAMAPK1FABP4FABP5CASP1
Hydrochloric Acid SCHEMBL1374028 0.98 LMNA (0.50) LMNAMAPK1FABP4FABP5CASP1
SCHEMBL28180751 0.98 LMNA (0.50) LMNAMAPK1FABP4FABP5CASP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12292363-B2 Method for preparing biological material having excellent light-transmitting property RIKEN (JP) 2025-05-06 — — US disclosed
CN-118931887-A Nitrilase cross-linked enzyme aggregate, and preparation method and application thereof 浙江工业大学 2024-11-12 — — CN disclosed
CN-111419830-B Phenylalkylcarbamate compounds for use in the prevention or treatment of epilepsy and epileptic related syndromes 比皮艾思药物研发有限公司 2024-01-30 — — CN disclosed
CN-115996905-A Phenylalkyl carbamate compounds for use in preventing or treating neurodegenerative diseases 生物药品解决方案有限公司 2023-04-21 — — CN disclosed
WO-2023058659-A1 POROUS THREE-DIMENSIONAL NETWORK STRUCTURE AND PRODUCTION METHOD THEREFOR キリンホールディングス株式会社 2023-04-13 — — WO disclosed
US-20220381657-A1 METHOD FOR PREPARING BIOLOGICAL MATERIAL HAVING EXCELLENT LIGHT-TRANSMITTING PROPERTY RIKEN (JP) 2022-12-01 — — US disclosed
EP-3997236-A1 PEPTIDES AND METHODS FOR THE CARBON-CARBON BOND FORMATION Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) 2022-05-18 — — EP disclosed
CN-110172021-B Separation and extraction method of (R) -o-chloromandelic acid 武汉武药制药有限公司 2022-04-22 — — CN disclosed
CN-110373762-B Preparation method of antibacterial blended yarn for underwear 海盐县硕创服装研究所 2022-04-12 — — CN disclosed
CN-109939092-B Phenyl carbamate compounds for use in preventing or treating pediatric epilepsy and epilepsy-related syndrome 比皮艾思药物研发有限公司 2022-03-22 — — CN disclosed
Send feedback